Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S. E. Aitken"'
Publikováno v:
Journal of Medical Screening. 5:73-80
Objective The Ontario breast screening program (OBSP) is a provincial breast screening programme offering two view mammography, clinical breast examination, instruction in breast self examination, and systematic two year recall to Ontario women 50 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c872692be1da66d1ad63ac9deb8f41
https://doi.org/10.1136/jms.5.2.73
https://doi.org/10.1136/jms.5.2.73
Autor:
Shailendra Verma, I. A. Prosser, M. Touchie, Jean A. Maroun, David J. Stewart, L. Robillard, S. E. Aitken, R. Earhart
Publikováno v:
Annals of Oncology. 3:401-403
Twenty-eight patients were treated with oral menogaril daily x 14 every 4 weeks. Granulocytopenia was dose-limiting at 50-60 mg/m2 per day. Neutropenic fever occurred in one patient. Thrombocytopenia occurred in 3 of 6 patients treated with menogaril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7cd454df7ee5124673cdfcbf97cf8a8
https://doi.org/10.1093/oxfordjournals.annonc.a058217
https://doi.org/10.1093/oxfordjournals.annonc.a058217
Publikováno v:
Canadian journal of public health = Revue canadienne de sante publique. 87(5)
Although Canadian Breast Screening Guidelines have been in place since 1988, participation rates have been suboptimal. The study objective was to describe changes in breast screening knowledge, attitudes, and practices among women aged 50 to 69 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ce250c8060a3c14ad3b4757ec23fddf
https://pubmed.ncbi.nlm.nih.gov/8972969
https://pubmed.ncbi.nlm.nih.gov/8972969
Autor:
D J, Stewart, S E, Aitken, S, Verma, J A, Maroun, L, Robillard, M, Touchie, I A, Prosser, R, Earhart
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 3(5)
Twenty-eight patients were treated with oral menogaril daily x 14 every 4 weeks. Granulocytopenia was dose-limiting at 50-60 mg/m2 per day. Neutropenic fever occurred in one patient. Thrombocytopenia occurred in 3 of 6 patients treated with menogaril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::74daf7ece41f2bcaa5e939e9e4eea0a2
https://pubmed.ncbi.nlm.nih.gov/1535508
https://pubmed.ncbi.nlm.nih.gov/1535508
Autor:
Elizabeth Eisenhauer, R. Buckman, J. Skillings, S. Verma, T. Vandenberg, David J. Stewart, B. Norris, Kathleen I. Pritchard, S. E. Aitken
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 3(3)
Summary The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of weekly oral menogaril as first-line therapy in 51 patients with incurable, metastatic or locally advanced breast cancer. While no prior chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2681a8b668355eae7b7fda2b9fd337c0
https://pubmed.ncbi.nlm.nih.gov/1534020
https://pubmed.ncbi.nlm.nih.gov/1534020
Autor:
A Ezzat, S. E. Aitken, R. Wierzbicki, James J. Rusthoven, Frances A. Shepherd, W K Evans, Jean A. Maroun, David J. Stewart
Publikováno v:
Cancer investigation. 8(3-4)
Thirty patients with a diagnosis of metastatic adenocarcinoma of the lung were entered on a trial to evaluate the antitumor efficacy of 5-fluorouracil 370 mg/m2 daily for 5 days every four weeks in combination with folinic acid 200 mg/m2, 60 min prio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c537081544754b443ed6952292062306
https://pubmed.ncbi.nlm.nih.gov/2207760
https://pubmed.ncbi.nlm.nih.gov/2207760
Publikováno v:
Annals of Oncology. 6:836-837
Summary Background Bladder cancer is a chemosensitive tumour, however, there is no effective therapy for patients with metastatic disease who failed to respond or relapsed after prior treatment with cisplatin-based chemotherapy. Single agent 5-fluoro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6d21f4f1966fb4ab7986d08630d933
https://doi.org/10.1093/oxfordjournals.annonc.a059325
https://doi.org/10.1093/oxfordjournals.annonc.a059325